Healthcare Today Michigan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.

Press releases published on October 19, 2026

Oct. 19, 2026

Biogen to Present New Data Across Nephrology Portfolio, Including Long-term EMPAVELI® (pegcetacoplan) Phase 3 Results, at American Society of Nephrology (ASN) Kidney Week

Indeterminate GlobeNewswire

Oct. 19, 2026

Cormedix Announces FDA Acceptance for Priority Review of Supplemental NDA for Rezzayo® (Rezafungin) for Prophylaxis of Invasive Fungal Diseases

Indeterminate GlobeNewswire

Oct. 19, 2026

Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at IDWeek 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Cytokinetics Announces Health Canada Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Indeterminate GlobeNewswire

Oct. 19, 2026

BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group

Indeterminate GlobeNewswire

Oct. 19, 2026

EyePoint Announces Strategic Prioritization

Indeterminate GlobeNewswire

Oct. 19, 2026

Kane Launches New Corporate Brand and Redesigned Website

Indeterminate GlobeNewswire

Oct. 19, 2026

Kraig Biocraft Laboratories Selected to Present to the International Sericultural Commission Congress on the Impact of Bioengineering on Commercial Silk Markets

Indeterminate GlobeNewswire

Oct. 19, 2026

Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics

Indeterminate GlobeNewswire

Oct. 19, 2026

aTyr Pharma Announces Research Collaboration with Montefiore Einstein

Indeterminate GlobeNewswire

Oct. 19, 2026

Parabilis Medicines to Present Updated Clinical Data for Zolucatetide in Patients with Desmoid Tumors at ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Ethyreal Bio Achieves Proof of Mechanism in First-in-Human Study of ETHY-001 and Initiates First Patient Cohorts to Advance Development in Thyroid Eye Disease (TED) and Graves’ Disease (GD)

Indeterminate GlobeNewswire

Oct. 19, 2026

Tonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Pain

Indeterminate GlobeNewswire

Oct. 19, 2026

Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Haleon Launches ‘Haleon Health House,’ a One-Day Interactive Wellness Pop-Up in Toronto

Indeterminate GlobeNewswire

Oct. 19, 2026

EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMD

Indeterminate GlobeNewswire

Oct. 19, 2026

Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer

Indeterminate GlobeNewswire

Oct. 19, 2026

Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM

Indeterminate GlobeNewswire

Oct. 19, 2026

Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP)

Indeterminate GlobeNewswire